TransMedics (TMDX) Cash from Investing Activities (2018 - 2026)
TransMedics (TMDX) posted quarterly Cash from Investing Activities of -$36.7 million for Q1 2026, down 35.58% year-over-year from -$56.9 million in Q1 2025, and down 136.28% quarter-over-quarter from -$15.5 million in Q4 2025.
TransMedics (TMDX) Cash from Investing Activities (2018 - 2026) Analysis & Trends
TransMedics' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$36.7 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 35.58% year-over-year to -$36.7 million; the TTM figure through Mar 2026 stood at -$68.9 million (up 38.6% YoY), while the FY2025 annual figure was -$59.3 million, up 54.18% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$36.7 million, down from -$15.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $24.7 million in Q3 2022, with the low at -$149.8 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is -$13.6 million (2024), against an average of -$21.5 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 478.73% in 2022, then slumped 4665.05% in 2024.
- TransMedics' Cash from Investing Activities stood at -$2.8 million in 2022, then slumped by 1412.95% to -$41.8 million in 2023, then surged by 67.46% to -$13.6 million in 2024, then fell by 14.02% to -$15.5 million in 2025, then tumbled by 136.28% to -$36.7 million in 2026.
- Business Quant data shows TMDX's Cash from Investing Activities at -$36.7 million in Q1 2026, -$15.5 million in Q4 2025, and -$7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.47 Bn | 193.87 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.67 Bn | 110.45 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 52.38 Bn | 48.13 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.76 Bn | 32.82 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 34.15 Bn | 32.04 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | -108.50 Mn |
| 10 | TransMedics | 3.21 Bn | 2.74 Bn | 113.20 Mn | -7.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.09 Mn |
| Jun 30, 2026 | -7.09 Mn |
| Mar 31, 2026 | -36.66 Mn |
| Mar 31, 2026 | -36.66 Mn |
| Dec 31, 2025 | -15.51 Mn |
| Dec 31, 2025 | -15.51 Mn |
| Sep 30, 2025 | -7.62 Mn |
| Sep 30, 2025 | -7.62 Mn |
| Jun 30, 2025 | -9.08 Mn |
| Jun 30, 2025 | -9.08 Mn |
| Mar 31, 2025 | -27.04 Mn |
| Mar 31, 2025 | -27.04 Mn |
| Dec 31, 2024 | -13.61 Mn |
| Dec 31, 2024 | -13.61 Mn |
| Sep 30, 2024 | -47.76 Mn |
| Sep 30, 2024 | -47.76 Mn |
| Jun 30, 2024 | -23.76 Mn |
| Jun 30, 2024 | -23.76 Mn |
| Mar 31, 2024 | -44.17 Mn |
| Mar 31, 2024 | -44.17 Mn |